Seeking Alpha

Mirati Therapeutics prices public offering, shares slide

  • Mirati Therapeutics (MRTX) prices its previously announced public offering at $17.50, a 3.4% discount to Wednesday's close. (8-K)
  • The shares fell 3.6% during Thursday's regular session.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector